Genetic editing of primary human dorsal root ganglion neurons using CRISPR-Cas9

Seph M. Palomino(Southwestern University), Amol Patwardhan(Southwestern University)

Scientific Reports

April 1, 2025

10.1038/s41598-025-91153-2

Cited by 4

Related Papers

Targeting the CaVα–CaVβ interaction yields an antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy

|Pain|2019|44

Genetic editing of primary human dorsal root ganglion neurons using CRISPR-Cas9 with functional confirmation

|bioRxiv (Cold Spring Harbor Laboratory)|2024|3